北美与欧洲外科主动脉瓣置换术围术期管理差异
该前瞻性观察队列在北美25个中心和欧洲13个中心纳入1118例需行SAVR的中度及以上主动脉瓣狭窄或反流患者,均植入同一款带支架生物瓣,围术期管理由各中心自主决定。欧洲患者年龄更大、体重指数更低、二叶式病变更少且基线主动脉瓣狭窄更重,出院抗凝更积极、住院时间更长、直接回家更少;30天再住院风险欧洲更低(8.5% vs 15.9%),1年时趋同(26.5% vs 28.1%)。
要点
- 北美与欧洲在患者选择、手术技术、抗血栓方案和出院管理上存在差异。
- 欧洲30天再住院率低于北美(8.5% vs 15.9%),1年时趋同。
- 各洲内不同国家间围术期管理也存在较大差异。
核心结论
- 当代SAVR围术期管理在北美与欧洲间存在患者选择、手术技术、抗血栓方案和出院管理差异,再住院率在大洲和国家间差异较大,试验设计与解读需考虑地理环境。
研究设计与样本
- 前瞻性观察队列评估新型带支架生物瓣的安全性和有效性,在北美25个中心(加拿大和美国)和欧洲13个中心(德国、荷兰、法国、英国、瑞士和意大利)纳入需行SAVR的中度及以上主动脉瓣狭窄或反流患者,共1118例。
- 所有患者均植入同一款生物瓣,围术期管理由参与中心自主决定,随访至1年。
主要发现
- 1118例中北美植入643例(58%),欧洲植入475例(42%)。
- 欧洲患者年龄更大、体重指数更低、二叶式病变更少且基线主动脉瓣狭窄程度更重。
- 欧洲出院时抗凝治疗更积极,住院时间更长,直接出院回家更少见。
- 30天再住院风险欧洲更低(8.5% vs 15.9%),1年随访时趋同(26.5% vs 28.1%)。
- 各洲内不同国家间围术期管理存在重大差异。
临床怎么用
- 解读SAVR围术期管理相关试验时需考虑北美与欧洲的地理设置差异。
- 设计SAVR试验时应考虑地理区域对围术期管理和再住院的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To describe differences between North America and Europe in the perioperative management of patients undergoing surgical aortic valve replacement (SAVR). METHODS: Patients with moderate or greater aortic stenosis or regurgitation requiring SAVR were enrolled in a prospective observational cohort evaluating the safety and efficacy of a new stented bioprosthesis at 25 centres in North America (Canada and the USA) and 13 centres in Europe (Germany, the Netherlands, France, the UK, Switzerland and Italy). While all patients underwent implantation with the same bioprosthetic model, perioperative management was left to the discretion of participating centres. Perioperative care was described in detail including outcomes up to 1-year follow-up. RESULTS: Among 1118 patients, 643 (58%) were implanted in North America, and 475 (42%) were implanted in Europe. Patients in Europe were older, had a lower body mass index, less bicuspid disease and worse degree of aortic stenosis at baseline. In Europe, anticoagulant therapy at discharge was more aggressive, whereas length of stay was longer, and discharges directly to home were less common. Rehospitalisation risk was lower in Europe at 30 days (8.5% vs 15.9%) but converged at 1-year follow-up (26.5% vs 28.1%). Within continents, there were major differences between individual countries concerning perioperative management. CONCLUSION: Contemporary perioperative management of SAVR patients varies between North America and Europe in patient selection, procedural techniques, antithrombotic regimen and discharge management. Furthermore, rehospitalisation differed largely between continents and countries. Hence, geographical setting must be considered during design and interpretation of trials on SAVR. TRIAL REGISTRATION NUMBER: NCT02088554.
引用
- Velders BJJ, Vriesendorp MD, De Lind Van Wijngaarden RAF, et al. Perioperative care differences of surgical aortic valve replacement between North America and Europe. Heart. 2023. PMID: 36963820. doi:10.1136/heartjnl-2023-322350
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。